AZ 5704

This orally bioavailable, highly potent and selective ATM kinase inhibitor (enzyme IC50 = 0.6 nM) demonstrates >600-fold selectivity and cellular activity (IC50 = 0.33 μM) . It is a valuable research tool for studying DNA damage response and has been shown to potentiate irinotecan's antitumor effects in vivo.